These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 29177700)

  • 1. Novel Mutations in PLOD2 Cause Rare Bruck Syndrome.
    Lv F; Xu X; Song Y; Li L; Asan ; Wang J; Yang H; Wang O; Jiang Y; Xia W; Xing X; Li M
    Calcif Tissue Int; 2018 Mar; 102(3):296-309. PubMed ID: 29177700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bruck syndrome 2 variant lacking congenital contractures and involving a novel compound heterozygous PLOD2 mutation.
    Mumm S; Gottesman GS; Wenkert D; Campeau PM; Nenninger A; Huskey M; Bijanki VN; Veis DJ; Barnes AM; Marini JC; Stolina M; Zhang F; McAlister WH; Whyte MP
    Bone; 2020 Jan; 130():115047. PubMed ID: 31472299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in PLOD2 cause autosomal-recessive connective tissue disorders within the Bruck syndrome--osteogenesis imperfecta phenotypic spectrum.
    Puig-Hervás MT; Temtamy S; Aglan M; Valencia M; Martínez-Glez V; Ballesta-Martínez MJ; López-González V; Ashour AM; Amr K; Pulido V; Guillén-Navarro E; Lapunzina P; Caparrós-Martín JA; Ruiz-Perez VL
    Hum Mutat; 2012 Oct; 33(10):1444-9. PubMed ID: 22689593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expanding the Clinical Spectrum of Phenotypes Caused by Pathogenic Variants in PLOD2.
    Leal GF; Nishimura G; Voss U; Bertola DR; Åström E; Svensson J; Yamamoto GL; Hammarsjö A; Horemuzova E; Papadiogannakis N; Iwarsson E; Grigelioniene G; Tham E
    J Bone Miner Res; 2018 Apr; 33(4):753-760. PubMed ID: 29178448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel mutations in FKBP10 and PLOD2 cause rare Bruck syndrome in Chinese patients.
    Zhou P; Liu Y; Lv F; Nie M; Jiang Y; Wang O; Xia W; Xing X; Li M
    PLoS One; 2014; 9(9):e107594. PubMed ID: 25238597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic and molecular characterization of Bruck syndrome (osteogenesis imperfecta with contractures of the large joints) caused by a recessive mutation in PLOD2.
    Ha-Vinh R; Alanay Y; Bank RA; Campos-Xavier AB; Zankl A; Superti-Furga A; Bonafé L
    Am J Med Genet A; 2004 Dec; 131(2):115-20. PubMed ID: 15523624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bruck syndrome in 13 new patients: Identification of five novel FKBP10 and PLOD2 variants and further expansion of the phenotypic spectrum.
    Otaify GA; Abdel-Hamid MS; Hassib NF; Elhossini RM; Abdel-Ghafar SF; Aglan MS
    Am J Med Genet A; 2022 Jun; 188(6):1815-1825. PubMed ID: 35278031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in FKBP10 cause recessive osteogenesis imperfecta and Bruck syndrome.
    Kelley BP; Malfait F; Bonafe L; Baldridge D; Homan E; Symoens S; Willaert A; Elcioglu N; Van Maldergem L; Verellen-Dumoulin C; Gillerot Y; Napierala D; Krakow D; Beighton P; Superti-Furga A; De Paepe A; Lee B
    J Bone Miner Res; 2011 Mar; 26(3):666-72. PubMed ID: 20839288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel homozygous 5 bp deletion in FKBP10 causes clinically Bruck syndrome in an Indonesian patient.
    Setijowati ED; van Dijk FS; Cobben JM; van Rijn RR; Sistermans EA; Faradz SM; Kawiyana S; Pals G
    Eur J Med Genet; 2012 Jan; 55(1):17-21. PubMed ID: 22085994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene mutation spectrum and genotype-phenotype correlation in a cohort of Chinese osteogenesis imperfecta patients revealed by targeted next generation sequencing.
    Liu Y; Asan ; Ma D; Lv F; Xu X; Wang J; Xia W; Jiang Y; Wang O; Xing X; Yu W; Wang J; Sun J; Song L; Zhu Y; Yang H; Wang J; Li M
    Osteoporos Int; 2017 Oct; 28(10):2985-2995. PubMed ID: 28725987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Mutations in SERPINF1 Result in Rare Osteogenesis Imperfecta Type VI.
    Wang JY; Liu Y; Song LJ; Lv F; Xu XJ; San A; Wang J; Yang HM; Yang ZY; Jiang Y; Wang O; Xia WB; Xing XP; Li M
    Calcif Tissue Int; 2017 Jan; 100(1):55-66. PubMed ID: 27796462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel compound heterozygous mutations in SERPINH1 cause rare autosomal recessive osteogenesis imperfecta type X.
    Song Y; Zhao D; Xu X; Lv F; Li L; Jiang Y; Wang O; Xia W; Xing X; Li M
    Osteoporos Int; 2018 Jun; 29(6):1389-1396. PubMed ID: 29520608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoblastic differentiation of bone marrow mesenchymal stromal cells in Bruck Syndrome.
    Kaneto CM; Lima PS; Zanette DL; Oliveira TY; de Assis Pereira F; Lorenzi JC; Dos Santos JL; Prata KL; Neto JM; de Paula FJ; Silva WA
    BMC Med Genet; 2016 May; 17(1):38. PubMed ID: 27146342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genotype-phenotype analysis of a rare type of osteogenesis imperfecta in four Chinese families with WNT1 mutations.
    Liu Y; Song L; Ma D; Lv F; Xu X; Wang J; Xia W; Jiang Y; Wang O; Song Y; Xing X; Asan ; Li M
    Clin Chim Acta; 2016 Oct; 461():172-80. PubMed ID: 27450065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in FKBP10, which result in Bruck syndrome and recessive forms of osteogenesis imperfecta, inhibit the hydroxylation of telopeptide lysines in bone collagen.
    Schwarze U; Cundy T; Pyott SM; Christiansen HE; Hegde MR; Bank RA; Pals G; Ankala A; Conneely K; Seaver L; Yandow SM; Raney E; Babovic-Vuksanovic D; Stoler J; Ben-Neriah Z; Segel R; Lieberman S; Siderius L; Al-Aqeel A; Hannibal M; Hudgins L; McPherson E; Clemens M; Sussman MD; Steiner RD; Mahan J; Smith R; Anyane-Yeboa K; Wynn J; Chong K; Uster T; Aftimos S; Sutton VR; Davis EC; Kim LS; Weis MA; Eyre D; Byers PH
    Hum Mol Genet; 2013 Jan; 22(1):1-17. PubMed ID: 22949511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel compound heterozygous variation in the
    Shang L; Shi W; Xu Y; Nong T; Li X; Li Z; Liu Y; Li J; Tang YP; Zhu M; Xu H
    Heliyon; 2024 Apr; 10(7):e28680. PubMed ID: 38590901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of Type I Collagen Telopeptide Lysyl Hydroxylation Causes Musculoskeletal Abnormalities in a Zebrafish Model of Bruck Syndrome.
    Gistelinck C; Witten PE; Huysseune A; Symoens S; Malfait F; Larionova D; Simoens P; Dierick M; Van Hoorebeke L; De Paepe A; Kwon RY; Weis M; Eyre DR; Willaert A; Coucke PJ
    J Bone Miner Res; 2016 Nov; 31(11):1930-1942. PubMed ID: 27541483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bruck syndrome: osteogenesis imperfecta and arthrogryposis multiplex congenita.
    Yapicioğlu H; Ozcan K; Arikan O; Satar M; Narli N; Ozbek MH
    Ann Trop Paediatr; 2009 Jun; 29(2):159-62. PubMed ID: 19460271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in FKBP10 can cause a severe form of isolated Osteogenesis imperfecta.
    Steinlein OK; Aichinger E; Trucks H; Sander T
    BMC Med Genet; 2011 Nov; 12():152. PubMed ID: 22107750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Follow-Up Outcomes of 19 Patients with Osteogenesis Imperfecta Type XI and Bruck Syndrome Type I Caused by FKBP10 Variants.
    Yüksel Ülker A; Uludağ Alkaya D; Elkanova L; Şeker A; Akpınar E; Akarsu NA; Uyguner ZO; Tüysüz B
    Calcif Tissue Int; 2021 Dec; 109(6):633-644. PubMed ID: 34173012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.